$GOVX
GeoVax Labs, Inc.

2014 Q4 Form 10-Q Financial Statement

#000143774914020379 Filed on November 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $223.1K $322.1K $1.004M
YoY Change 27.67% -67.93% 56.91%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $680.0K $410.0K $320.0K
YoY Change 51.11% 28.13% -3.03%
% of Gross Profit
Research & Development $470.0K $425.5K $879.1K
YoY Change -21.67% -51.6% 46.52%
% of Gross Profit
Depreciation & Amortization $20.00K $20.00K $10.00K
YoY Change -33.33% 100.0% -50.0%
% of Gross Profit
Operating Expenses $1.150M $837.3K $1.196M
YoY Change 9.52% -29.96% 27.19%
Operating Profit -$515.2K -$191.3K
YoY Change 169.27%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $711.00 $1.197K
YoY Change -40.6%
Pretax Income -$920.0K -$510.0K -$190.0K
YoY Change 5.75% 168.42% -36.67%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$923.6K -$514.5K -$190.1K
YoY Change 5.95% 170.59% -36.62%
Net Earnings / Revenue -414.0% -159.74% -18.94%
Basic Earnings Per Share -$0.03 -$0.02 -$0.01
Diluted Earnings Per Share -$591.1B -$406.3B -$175.5B
COMMON SHARES
Basic Shares Outstanding 31.95M
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.100M $860.0K $1.720M
YoY Change -56.18% -50.0% 8.86%
Cash & Equivalents $1.102M $862.2K $1.721M
Short-Term Investments
Other Short-Term Assets $40.00K $60.00K $50.00K
YoY Change 0.0% 20.0% 0.0%
Inventory
Prepaid Expenses
Receivables $80.00K $0.00 $30.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.225M $926.4K $1.790M
YoY Change -54.58% -48.25% -4.79%
LONG-TERM ASSETS
Property, Plant & Equipment $96.69K $113.2K $140.0K
YoY Change -19.57% -19.12% 16.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.01K $13.51K $10.00K
YoY Change 0.0% 35.1% 0.0%
Total Long-Term Assets $107.7K $126.7K $170.0K
YoY Change -23.74% -25.45% 6.25%
TOTAL ASSETS
Total Short-Term Assets $1.225M $926.4K $1.790M
Total Long-Term Assets $107.7K $126.7K $170.0K
Total Assets $1.333M $1.053M $1.960M
YoY Change -53.05% -46.27% -3.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.62K $82.20K $90.00K
YoY Change -64.34% -8.67% 28.57%
Accrued Expenses $52.49K $8.279K $120.0K
YoY Change -45.55% -93.1% 20.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $187.0K $170.2K $230.0K
YoY Change -40.12% -25.99% -32.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $187.0K $170.2K $230.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $190.0K $170.0K $230.0K
YoY Change -38.71% -26.09% -32.35%
SHAREHOLDERS EQUITY
Retained Earnings -$29.79M
YoY Change
Common Stock $30.86M $28.89M
YoY Change 9.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.146M $882.9K $1.740M
YoY Change
Total Liabilities & Shareholders Equity $1.333M $1.053M $1.960M
YoY Change -53.05% -46.27% -3.92%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$923.6K -$514.5K -$190.1K
YoY Change 5.95% 170.59% -36.62%
Depreciation, Depletion And Amortization $20.00K $20.00K $10.00K
YoY Change -33.33% 100.0% -50.0%
Cash From Operating Activities -$630.0K -$490.0K -$70.00K
YoY Change -23.17% 600.0% -69.57%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K -$90.00K
YoY Change -66.67%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 -$30.00K -$90.00K
YoY Change -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 870.0K 0.000 0.000
YoY Change -46.3%
NET CHANGE
Cash From Operating Activities -630.0K -490.0K -70.00K
Cash From Investing Activities 0.000 -30.00K -90.00K
Cash From Financing Activities 870.0K 0.000 0.000
Net Change In Cash 240.0K -520.0K -160.0K
YoY Change -70.0% 225.0% -30.43%
FREE CASH FLOW
Cash From Operating Activities -$630.0K -$490.0K -$70.00K
Capital Expenditures $0.00 -$30.00K -$90.00K
Free Cash Flow -$630.0K -$460.0K $20.00K
YoY Change -23.17% -2400.0% -108.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86602
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
541189
dei Entity Central Index Key
EntityCentralIndexKey
0000832489
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31950813
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Amendment Flag
AmendmentFlag
false
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Registrant Name
EntityRegistrantName
GeoVax Labs, Inc.
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
govx Operating Lease Term Of Lease
OperatingLeaseTermOfLease
P5Y60D
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
82197
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
155943
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Document Type
DocumentType
10-Q
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8279
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96406
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
541169
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
498666
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28863162
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28239392
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
193803
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2839576
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12500000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10300000
CY2014Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8400
CY2014Q3 us-gaap Assets
Assets
1053128
CY2013Q4 us-gaap Assets
Assets
2839576
CY2014Q3 us-gaap Assets Current
AssetsCurrent
926391
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2698339
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2513861
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1035925
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862191
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1720616
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1651670
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
684691
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.54
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8284826
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12696641
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25718037
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23765180
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25718037
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23765180
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
25718
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
23765
CY2014Q3 us-gaap Deposits Assets
DepositsAssets
11010
CY2013Q4 us-gaap Deposits Assets
DepositsAssets
11010
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50003
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52652
CY2014Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
28862055
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
27052085
CY2014Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
79757
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
411814
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
316452
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1128478
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1345179
CY2013Q4 us-gaap Grants Receivable
GrantsReceivable
140909
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-142116
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-101505
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20631
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5961
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-140909
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-241234
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
711
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1197
us-gaap Investment Income Interest
InvestmentIncomeInterest
3201
us-gaap Investment Income Interest
InvestmentIncomeInterest
3429
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1053128
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1616167
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-872040
us-gaap Net Income Loss
NetIncomeLoss
-1809970
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1643333
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35503
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
170233
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
312349
us-gaap Net Income Loss
NetIncomeLoss
-1413229
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-514515
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-190148
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
711
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1197
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3201
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3429
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
837312
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
1195556
us-gaap Operating Expenses
OperatingExpenses
2473038
us-gaap Operating Expenses
OperatingExpenses
3659470
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-515226
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-191345
us-gaap Operating Income Loss
OperatingIncomeLoss
-1813171
us-gaap Operating Income Loss
OperatingIncomeLoss
-1416658
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
32710
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13510
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21010
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35503
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86602
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
64200
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43569
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1643333
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
654396
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
618893
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113227
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120227
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
425498
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
879104
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1344560
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2314291
CY2014Q3 us-gaap Revenue From Grants
RevenueFromGrants
322086
CY2013Q3 us-gaap Revenue From Grants
RevenueFromGrants
1004211
us-gaap Revenue From Grants
RevenueFromGrants
659867
us-gaap Revenue From Grants
RevenueFromGrants
2242812
us-gaap Share Based Compensation
ShareBasedCompensation
165638
us-gaap Share Based Compensation
ShareBasedCompensation
354769
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
616594
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
231444
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7500
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1197044
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
973100
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.79
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.22
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.29
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
882895
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
2527227
CY2014Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
211000
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25325141
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21666610
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25109811
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20979675

Files In Submission

Name View Source Status
0001437749-14-020379-index-headers.html Edgar Link pending
0001437749-14-020379-index.html Edgar Link pending
0001437749-14-020379.txt Edgar Link pending
0001437749-14-020379-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
govx-20140930.xml Edgar Link completed
govx-20140930.xsd Edgar Link pending
govx-20140930_cal.xml Edgar Link unprocessable
govx-20140930_def.xml Edgar Link unprocessable
govx-20140930_lab.xml Edgar Link unprocessable
govx-20140930_pre.xml Edgar Link unprocessable
govx20140930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending